Shenzhen YHLO Biotech Résultats passés
Passé contrôle des critères 2/6
Shenzhen YHLO Biotech has been growing earnings at an average annual rate of 13.9%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 16.8% per year. Shenzhen YHLO Biotech's return on equity is 8.8%, and it has net margins of 15.2%.
Informations clés
13.9%
Taux de croissance des bénéfices
14.0%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 16.0% |
| Taux de croissance des recettes | 16.8% |
| Rendement des fonds propres | 8.8% |
| Marge nette | 15.2% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)
Oct 31
Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return
Oct 12Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings
Aug 30Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?
Jul 18Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing
May 23Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 01There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital
Mar 19Ventilation des recettes et des dépenses
Comment Shenzhen YHLO Biotech gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 1,902 | 289 | 592 | 329 |
| 30 Jun 24 | 1,938 | 387 | 591 | 330 |
| 31 Mar 24 | 1,824 | 340 | 569 | 338 |
| 31 Dec 23 | 2,053 | 355 | 573 | 314 |
| 30 Sep 23 | 2,397 | 424 | 466 | 275 |
| 30 Jun 23 | 2,719 | 488 | 451 | 247 |
| 31 Mar 23 | 3,271 | 582 | 548 | 243 |
| 31 Dec 22 | 3,981 | 1,012 | 629 | 238 |
| 30 Sep 22 | 3,450 | 923 | 667 | 208 |
| 30 Jun 22 | 2,967 | 782 | 606 | 193 |
| 31 Mar 22 | 2,312 | 678 | 463 | 154 |
| 31 Dec 21 | 1,178 | 205 | 299 | 129 |
| 30 Sep 21 | 1,147 | 216 | 269 | 128 |
| 30 Jun 21 | 1,118 | 198 | 252 | 126 |
| 31 Mar 21 | 1,020 | 198 | 228 | 111 |
| 01 Jan 21 | 999 | 211 | 220 | 102 |
| 31 Dec 19 | 877 | 108 | 223 | 80 |
| 31 Dec 18 | 729 | 38 | 180 | 51 |
Des revenus de qualité: 688575 has high quality earnings.
Augmentation de la marge bénéficiaire: 688575's current net profit margins (15.2%) are lower than last year (17.7%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 688575's earnings have grown by 13.9% per year over the past 5 years.
Accélération de la croissance: 688575's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 688575 had negative earnings growth (-31.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Rendement des fonds propres
ROE élevé: 688575's Return on Equity (8.8%) is considered low.